AntriaBio
Home
About
Corporate Presentation
Leadership
Board of Directors
Scientific Advisory Board
Pipeline
Overview
RZ358
RZ402
Clinical Trials
Publications
News
Press Releases
Media
IR Calendar
Publications
Investors
Overview
IR Overview
News / Events
Press Releases
IR Calendar
Corporate Presentation
Publications
Email Alerts
Company Information
Management Team
IR Contacts
Stock Data
Quote
Charts
Historical Data
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Analyst Coverage
Analyst Coverage
Corporate Governance
Board of Directors
Corporate Governance Documents
Careers
Contact
All SEC Filings
Home
Investors
SEC Filings
All SEC Filings
Investors
Overview
News / Events
Company Information
Stock Data
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Analyst Coverage
Corporate Governance
All SEC Filings
Filter Filings:
View All
10-K
10-K/A
10-Q
10-Q/A
3
3/A
4
424B3
8-A12B
8-A12G
8-K
8-K/A
CERT
CORRESP
CT ORDER
D
D/A
DEF 14A
DEF 14C
EFFECT
NT 10-K
NT 10-Q
POS AM
PRE 14A
PRE 14C
PRER14A
PRER14C
RW
S-1
S-1/A
S-3
S-3/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC 14F1
SC TO-I
SC TO-I/A
UPLOAD
Date
Form
Description
Docs
XBRL
Pages
11/10/20
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
12
11/09/20
CERT
1
11/06/20
8-K
Current report filing
Related Documents
EX-99.1
5
11/05/20
3/A
Initial statement of beneficial ownership of securities
2
11/04/20
8-A12B
Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
3
10/30/20
3
Initial statement of beneficial ownership of securities
2
10/22/20
D
Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.
6
10/14/20
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
12
10/14/20
4
Statement of changes in beneficial ownership of securities
2
10/13/20
10-K
Annual report pursuant to Section 13 and 15(d)
Related Documents
EX-10.21
EX-21.1
EX-23.1
EX-31.1
EX-31.2
EX-32.1
EX-32.2
93
<< Previous
1
2
3
4
5
6
7
8
9
10
...43
Next >>